Page last updated: 2024-10-20

spermidine and DDPAC

spermidine has been researched along with DDPAC in 1 studies

Research Excerpts

ExcerptRelevanceReference
" We have tested the therapeutic potential of rapamycin, an inhibitor of the mammalian target of rapamycin (mTOR) and three other autophagy activators (spermidine, carbamazepine, and tamoxifen) in a FTLD-U mouse model with TDP-43 proteinopathies."3.78Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. ( Guo, BS; Liu, YC; Shen, CK; Tsai, KJ; Wang, IF; Wu, CC; Yang, CH, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, IF1
Guo, BS1
Liu, YC1
Wu, CC1
Yang, CH1
Tsai, KJ1
Shen, CK1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Rapamycin (Sirolimus) Treatment for Amyotrophic Lateral Sclerosis[NCT03359538]Phase 263 participants (Actual)Interventional2017-09-19Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for spermidine and DDPAC

ArticleYear
Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Sep-11, Volume: 109, Issue:37

    Topics: Analysis of Variance; Animals; Autophagy; Blotting, Western; Carbamazepine; Caspase 3; Fluorometry;

2012